Dr. Jaron J. Kee, MD

Dr. Kee practices at Presbyterian Medical Group in Albuquerque, New Mexico.

Dr. Kee's NPI, 1073075065, was assigned on April 1, 2019. Dr. Kee holds New Mexico license MD2022-1077.

Dr. Kee's primary practice is Presbyterian Medical Group, at 3630 Las Estancias SW Dr, Albuquerque, NM 87121 in Bernalillo County. The practice phone is (505) 823-8556.

Dr. Kee's primary practice is Presbyterian Medical Group in Albuquerque, New Mexico. Dr. Kee is also affiliated with Presbyterian Hospital. The medical group on file is Presbyterian Medical Group. Dmand AI also links Dr. Kee to 2 more medical groups and 1 community health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kee practices, 2 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Kee's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Kee is licensed in New Mexico.

CMS data shows 133 Medicare services from Dr. Kee across 5 procedure codes in 2024, for 80 Medicare patients. Medicare paid $8,489 for them.

CMS counts 80 Medicare patients who saw Dr. Kee in 2024. The largest group is 65 to 74, with 35 patients. 75% of them have high blood pressure, and 48% have high cholesterol. 54% are also on Medicaid. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kee's median patient age at 56, with 49% women.

In 2024, Dr. Kee wrote 900 Medicare Part D claims for 188 patients. 83% of them were for generic drugs. CMS names the drug for 506 of them, across 24 drugs with 11 or more claims each, at $68,325 in total drug cost. In 2023, CMS named 369 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Kee for performance year 2024, reported as part of a group. Dr. Kee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kee as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Kee. Dr. Kee's most frequent co-author is Mary Elizabeth Logue, MD.

CMS Open Payments shows 2 general payments to Dr. Kee from 2 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $117.